Health & Biotech
ASX Health Stocks: Respiri lifts 14pc after giving update on US market
Health & Biotech
Neurotech International appoints industry expert during key phase of growth
Health & Biotech
PharmAust says MPL can double the life expectancy of dogs with cancer; US trials to begin
Health & Biotech
Power move: Incannex attracts global regulatory affairs expert, Novo Nordisk exec to board
Health & Biotech
Neuroscientific Biopharma receives $1.13m in R&D incentive to progress EmtinB
Health & Biotech
Prescient secures OmniCAR cell lines for upcoming clinical trials
Health & Biotech
ASX Health Stocks: Emyria on a high after getting ethics approval, Twiggy’s investment
Health & Biotech
Twiggy’s Tattarang is getting into health tech – which ASX stocks will benefit?
Health & Biotech
ASX Health Stocks: Mesoblast raise signals potential comeback for biotechs
Health & Biotech
Kazia says diversification is the key to drug development
Health & Biotech
ASX Health Stocks: Avita tumbles 16pc as RECELL study results disappoint investors
Health & Biotech
Weed Week: Ice-T plans to open dispensary and Snoop Dogg’s venture capital firm backs weed snacks
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.